9 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Clopidogrel to Ticagrelor ... to Clopidogrel, Ticagrelor ... : Prasugrel to Ticagrelor ... , Ticagrelor to ... #antiplatelet #ticagrelor
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
prasugrel (P) or ticagrelor ... last prasugrel or ticagrelor ... changing from ticagrelor ... the last dose of ticagrelor ... #antiplatelet #ticagrelor
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous
Clopidogrel #Prasugrel #Ticagrelor
Antiplatelet Conversion - P2Y12 Inhibitor Switching
 • Clopidogrel (Plavix)
 • Prasugrel (Effient)
 • Ticagrelor (Brilinta)
Clopidogrel and
Prasugrel (Effient) • Ticagrelor ... Ticagrelor, a noncompetitive ... Reversible inhibitor: ticagrelor
Oral P2Y12 Inhibitor Pharmacology

 • Clopidogrel
 • Prasugrel
 • Ticagrelor

By Kyle Fischer, PharmD @Kfischer_10

#P2Y12 #Inhibitor #Pharmacology
Prasugrel • Ticagrelor
Very Quick Guide to Reversing Antithrombotic Therapy
Aspirin 
Clopidogrel 
Prasugrel 
Ticagrelor 
Abciximab 
Tirofiban 
Eptifibatide 
Unfractionated Heparin 
Low
Prasugrel Ticagrelor
Quick Guide to Reversing Antiplatelet and Antithrombotic Therapy
Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Abciximab, Tirofiban, Eptifibatide, Unfractionated Heparin,
Clopidogrel, Prasugrel, Ticagrelor
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
clopidogrel, prasugrel, ticagrelor
Cangrelor - Pharmacology
Cangrelor (Kengreal) is a parenteral analogue of adenosine triphosphate
Cangrelor binds reversibly to the platelet
subtherapeutic levels • Ticagrelor ... Ticagrelor's half-life